Global Fund to Fight AIDS to slash over 100 jobs

May 2, 2012

The Global Fund to Fight Aids, Tuberculosis and Malaria said Wednesday it is cutting over 100 jobs, in an overhaul after a rough financial period and a scandal in which millions of dollars went missing.

"The reorganisation process is nearing completion and we estimate that between 110 and 120 people will leave the Global Fund," said spokeswoman Veronique Taveau.

"Some of them decided to leave, while others were unsuccessful in finding new positions within the organisation."

Taveau said final details on the restructuring would be announced at the fund's next board meeting on May 10 and 11.

The Geneva-based fund has risen to become a major player in worldwide public health since its founding in 2002.

But it has hit difficult times since the , which curtailed donor spending, and the departure of its executive director earlier this year after auditors found that $34 million (26 million euros) had gone missing or been siphoned off in four .

Former executive director Michel Kazatchkine denies any wrongdoing, but announced on January 24 that he was stepping down amid a management reshuffle. He has been replaced by Gabriel Jaramillo in the post of general manager.

The is the main source of funding worldwide for HIV/AIDS, and malaria initiatives, with grants totaling $22.6 billion for more than 1,000 programmes in 150 countries.

Explore further: Global Fund for world health halts new programs

Related Stories

Global Fund for world health halts new programs

November 24, 2011
(AP) -- The world's biggest financier in the fight against three killer diseases says it has run out of money to pay for new grant programs for the next two years - a situation likely to hit poor AIDS patients around the ...

Ukraine urged to step up AIDS fight

January 16, 2012
(AP) -- The head of a global health fund on Monday urged Ukraine to step up its efforts to fight the HIV/AIDS epidemic, Europe's largest.

Global AIDS Fund head to quit

January 24, 2012
The Global Fund to Fight AIDS announced on Tuesday that its head Michel Kazatchkine will quit but denied media reports that it was connected to his links with French first lady Carla Bruni-Sarkozy.

Gates injects $750M in troubled Global Fund

January 26, 2012
(AP) -- Bill Gates pledged $750 million on Thursday to fight three killer diseases and rescue a beleaguered health fund whose financial losses have cost it donor support.

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.